Literature DB >> 19741264

Chronic obstructive pulmonary disease in men and women: myths and reality.

Pat G Camp1, Denis E O'Donnell, Dirkje S Postma.   

Abstract

Chronic diseases have a variable impact on men and women due to the complex interaction between biological sex and environmental risk factors to which men and women are differentially exposed. Sex differences have not been adequately explored in chronic obstructive pulmonary disease (COPD), as most studies have either had small sample sizes or not enough women to allow for accurate comparisons. This article will address sex differences in susceptibility, expression of COPD subtypes, and activity-related breathlessness, and will identify key areas for further investigation.

Entities:  

Mesh：

Year:  2009        PMID： 19741264     DOI： 10.1513/pats.200904-018DS

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


  10 in total

Review 1.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

2.  Combined effect of lung function level and decline increases morbidity and mortality risks.

Authors:  Penelope Baughman; Jacob L Marott; Peter Lange; Christopher J Martin; Anoop Shankar; Edward L Petsonk; Eva Hnizdo
Journal:  Eur J Epidemiol       Date:  2012-12-14       Impact factor: 8.082

3.  Hospital-reported data on the pneumonia quality measure "Time to First Antibiotic Dose" are not associated with inpatient mortality: results of a nationwide cross-sectional analysis.

Authors:  Erin Quattromani; Emilie S Powell; Rahul K Khare; Navneet Cheema; Kori Sauser; Usha Periyanayagam; Matthew J Pirotte; Joe Feinglass; D Mark Courtney
Journal:  Acad Emerg Med       Date:  2011-05-05       Impact factor: 3.451

4.  Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease.

Authors:  Rajni Kant Shukla; Surya Kant; Sandeep Bhattacharya; Balraj Mittal
Journal:  Oman Med J       Date:  2012-07

5.  Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease.

Authors:  Carlos H Martinez; Swetha Raparla; Craig A Plauschinat; Nicholas D Giardino; Barbara Rogers; Julien Beresford; Judith D Bentkover; Amy Schachtner-Appel; Jeffrey L Curtis; Fernando J Martinez; MeiLan K Han
Journal:  J Womens Health (Larchmt)       Date:  2012-12       Impact factor: 2.681

6.  Sex differences in the response of the alveolar macrophage proteome to treatment with exogenous surfactant protein-A.

Authors:  David S Phelps; Todd M Umstead; Joanna Floros
Journal:  Proteome Sci       Date:  2012-07-23       Impact factor: 2.480

7.  Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.

Authors:  Justyna Pollok; Joep Em van Agteren; Adrian J Esterman; Kristin V Carson-Chahhoud
Journal:  Cochrane Database Syst Rev       Date:  2019-03-06

8.  Sex-related differences in respiratory symptoms: results from the BOLD Study.

Authors:  Bernd Lamprecht; Lowie E Vanfleteren; Michael Studnicka; Michael Allison; Mary Ann McBurnie; William M Vollmer; Wan Cheng Tan; Rune Nielsen; Pawel Nastalek; Louisa Gnatiuc; Bernhard Kaiser; Christer Janson; Emiel F M Wouters; Peter Burney; A Sonia Buist
Journal:  Eur Respir J       Date:  2013-09       Impact factor: 16.671

9.  Mechanisms of ECG signs in chronic obstructive pulmonary disease.

Authors:  Marte Strømsnes Larssen; Kjetil Steine; Janne Mykland Hilde; Ingunn Skjørten; Christian Hodnesdal; Knut Liestøl; Knut Gjesdal
Journal:  Open Heart       Date:  2017-03-22

10.  Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.

Authors:  Jadwiga A Wedzicha; Dave Singh; Ioanna Tsiligianni; Christine Jenkins; Sebastian Fucile; Robert Fogel; Steven Shen; Pankaj Goyal; Karen Mezzi; Konstantinos Kostikas
Journal:  Respir Res       Date:  2019-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.